Tags Posts tagged with "cannabis stock"

cannabis stock

0 1756
marijuana

$UBQU Premieres New 24 Hour Interactive Customer Support Phone System

 

Ubiquitech Software Corp. ( OTC PINK : UBQU ), through its operating subsidiary HempLife Today™, is announcing the development and implementation of its new IVR (Interactive Voice Response), 24 hour toll-free customer support phone system, developed to improve customer support, customer satisfaction, and increase sales volume.

This new IVR system was developed using one of the most technologically advanced software applications in the industry, and will help the Company to better serve its daily increase of customers for its growing line of CannazALL™ CBD products derived from Hemp, by offering an easier way to learn more about the Company, the products, and to better speak to a specialist who can assist in taking an order.


Click Here Now To Read Full PR


7 Cannabis Company Developments to Highlight

This week was a busy week for cannabis stocks and this is important as it follows a couple rough weeks of trading. Some of the important develops we think investors should take note of, include…[continue reading]


Click Here Now To Read Full Article


#ICYMI: Will This Marijuana Stock See a Record Setting Year in 2017?

Among the many segments of the marijuana industry that we cover, CBD has taken on a big role not only for its biotech-based applications but also for its uses outside of the health sciences sector. And with the growth that the market as a whole could be set to see, CBD companies are definitely in the spotlight for the foreseeable future.

One Marijuana Stock that we’ve been reporting on since late last year has been Ubiquitech Software Corp (UBQU). Now don’t let the name fool you, this company, through its subsidiary HempLife Today™ is breaking barriers with its CBD brand while also hitting major milestones over the last year. What could be best of all is that 2017 could already have the stage set for yet another record setting period in (UBQU)’s company history.


Click Here Now To Read Full Article


 

Pursuant to an agreement between MAPH and Ubiquitech Software Corp., we were hired for a period beginning November 11 2016 and ending May 11, 2017 to publicly disseminate information about (UBQU) including on the Website and other media including Facebook and Twitter. We are being paid $0 (CASH) for or were paid “10 million” shares of restricted common shares. We may buy or sell additional shares of (UBQU) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 1460

Rocky Mountain High Brands Discusses Series A Preferred Restructuring

DALLAS, March 17, 2017 (GLOBE NEWSWIRE) — Rocky Mountain High Brands, Inc. (RMHB), a fully reporting consumer goods company specializing in hemp-infused food and beverage products and a naturally high alkaline water, offered an explanation of its recent move to increase the voting and conversion rights of its Series A Preferred Stock.

Michael Welch, President and Chief Executive Officer of Rocky Mountain High Brands, Inc., said, “With the recent acquisition by LSW Holdings, LLC of the Company’s Series A Preferred Stock, we have reviewed our equity structure and are making changes to it to both protect the Company and to provide for its future growth. The Series A Preferred Stock is the Control Block for the Company. It has special rights associated with it and is not designed or intended to be converted to Common Stock. Changes to its voting rights and conversion rights were made to ensure that LSW Holdings maintains control of the Company in the event of corporate actions such as a merger/acquisition or hostile takeover.”

Welch continued, “Lily Li and other principals and representatives of LSW Holdings were in Dallas this week to meet our Rocky Mountain High team and discuss future plans for the Company. With the opportunities that LSW Holdings will bring into the Company, we need to protect the Company and its shareholders from a hostile takeover or any other uninvited action not in the best interest of the Company or its shareholders. The restructuring of the Series A Preferred Stock voting and conversion rights are a part of that plan.”

About Rocky Mountain High Brands:

ROCKY MOUNTAIN HIGH BRANDS, INC., is a consumer goods company specializing in brand development of health conscious, hemp-infused food and beverage products. The Company currently markets a lineup of four naturally flavored hemp-infused beverages (Citrus Energy, Black Tea, Mango Energy and Lemonade) and a low calorie Coconut Lime Energy drink. Rocky Mountain High Brands also offers hemp-infused 2oz. Mango Energy Shots and Mixed Berry Energy Shots. The Company recently launched a naturally high alkaline spring water, Eagle Spirit Spring Water.

For interested investors, our stock symbol is RMHB.

For ordering information please visit: LiveRockyMountainHigh.com

For corporate information please visit: RockyMountainHighBrands.com

For information on our high alkaline water visit: EagleSpiritWater.com

For Rocky Mountain High Distribution Contact:

Chuck Smith (972) 955-0964
chuck@rockymountainhighbrands.com

Visit us on Facebook: https://www.facebook.com/rockymountainhighbrands?fref=nf

Visit us on Twitter:
#GetYourHempOn

Visit us at Investors Hangout: http://investorshangout.com/Rocky-Mountain-High-Brands-Inc-RMHB-69150/

Investors Hangout is the only authorized Investors blog page for Rocky Mountain High Brands, Inc.

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

1 12132

How Have Marijuana Stocks Performed Post Trump?

Here we are, the official inauguration day of our 45th President of the United States of America, Donald Trump. A lot has been said about him over the last few years during the election race but what many may not have expected was a clear “Trump Bump” for marijuana stocks.

As we’ve said in the past, a lot of marijuana stocks are event driven. Going all the way back to 2014 and during the years to follow, catalysts in the cannabis market can be tied to actual events in many cases. For this most recent jump in marijuana stock prices, we see that an election year and a not so conservative President may be the event to thank for this.

In this article we’ll briefly explore some of the most active and most bullish marijuana stocks in the market to give a clear example of “where we’ve been” and what we might be able to look forward to as to “where we’re going”.

OWC Pharmaceutical Research Corp. (OWCP) 3,512%

This company has been building steam since October and just recently went into overdrive to all time highs. Through its subsidiary, One World Cannabis, the Israeli-based company develops cannabinoid-based therapies that target different medical conditions. This was another cannabis biotech company that saw the impact of Trump coming into office instead of Clinton (who was very bearish on biotech).

In late October just before the elections, OWCP saw its first noticeable move from under $0.03 and initially ran to highs of $0.215. Following the consolidation period heading into the end of the year (as most marijuana stocks saw), January opened the door for this stock to run as high as $0.95

OWCP_Marijuana_Stocks

 

Rocky Mountain High Brands (RMHB)
271%

We’ve reported on this company and followed it for a few years. Even before when it was “Totally Hemp Crazy (THCZ)” this stock saw one of the biggest breakouts that we’ve every witnessed. It went from sub penny to highs of 0.32 within weeks. Now it appears that chart has demonstrated a similar Trump Bump that many of the other marijuana stocks have also seen.

In early October, volume began to build, RMHB ran from $0.031 to highs of $0.07. After consolidating back to 0.03-0.04, RMHB has now seen its 2017 rally trigger and has now managed to run past $0.11. Rocky Mountain is a consumer goods company specializing in brand development of health conscious, hemp-infused food and beverage products. The Company currently markets a lineup of four naturally flavored hemp-infused beverages (Citrus Energy, Black Tea, Mango Energy and Lemonade) and a low-calorie Coconut Lime Energy drink. Rocky Mountain High Brands also offers hemp-infused 2oz. Mango Energy Shots and Mixed Berry Energy Shots, as well as a Relaxation Brownie.

Marijuana Stock

Ubiquitech Software Corp. (UBQU)
304%

UBQU follows a similar trend where even though it hasn’t broken above its year end highs, the stock has seen a reversal that started at the beginning of 2017. A lot of questions were raised regarding a previously announced name change and recently the company gave clear guidance on this for 2017 that has brought attention back to the stock from market bulls. Its final name change will be Endo BioSciences Inc., and HempLife Today™ will continue to be the main subsidiary of the company.

HempLifeToday™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers HempLifeToday.com™ has developed multiple and proprietary CannazALL™ CBD oil products that include; its popular CBD Tinctures, Oils, GelCaps, CBD Powder, Skin Salve, Wax Crumble, and e-liquid.

marijuana stocks

mCig, Inc. (MCIG)
1,265%

A company that we’ve kept up with for the better part of the last year, MCIG became another clear example of what marijuana stocks have started to look like after Donald Trump was elected President. The company has been making many key strides over the last few months including posting some of its best numbers in history.

This includes MCIG currently holding over $10 million in order/contract backlog (as of their last PR in December). In similar fashion to OWCP, shares of MCIG saw a bump in late October when the stock moved from under $0.04 to as high as $0.218. After consolidating in early December, MCIG manage to rally strong heading into the end of the year and recently hit highs of $0.505.

cannabis stocks

Axim Biotechnologies, Inc. (AXIM)
3,941%

Another company that we’ve been following very closely, this has been one of the biggest runners of the year amid heavy volatility. Another cannabis biotech, the company focuses on the research, development and production of cannabis-based pharmaceutical, nutraceutical and cosmetic products. Our flagship products include CanChew®, a CBD-based controlled release chewing gum, and MedChew Rx, a combination CBD/THC gum that is undergoing clinical trials for the treatment of pain and spasticity associated with multiple sclerosis. MJNA is also an investor in AXIM.

In late October the stock was trading just under $0.50 moved to a high of $10 before consolidating to levels between $7.50-$8. Wouldn’t you know it, heading into the beginning of 2017 the stock broke the sideways trend and moved to highs of $19.80.

cannabis stock

Vitality Biopharma (VBIO)
361%

A company that many of us are familiar with, this cannabis biotech had a smaller run a few weeks before we started picking up coverage. In early October, the stock moved up from around $0.92 to highs of $1.84. After pulling back to lows in December, we began looking at this company at $0.98 and watched as it ran to highs of $4.24. The company is a cannabis biotech focusing on treating disease through its prodrug utilizing cannabinoids for the treatment of serious neurological and inflammatory disorders.

marijuana

Cannabis Science (CBIS)
469%

The company specializes in the development of cannabinoid-based medications and recently announced a collaborative research agreement with Dana Farber/Harvard Cancer Center. Their initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.

From October 3 to October 19 CBIS jumped from $0.0169 to as high as $0.077. After pulling in during December, the stock kicked off the new year with a big bull run all the way to highs of $0.0961 for the year so far.

cannabis

Hemp Inc. (HEMP)
103%

One of the most vocal companies on Hemp production in the US, Hemp Inc. They’ve continued to push for a ubiquitous acceptance for all uses of the hemp plant for years now and have targeted North Carolina to grow over 3,000 acres of hemp.

“We are proud to collaborate with other American industrial hemp farmers as we now become part of the modern industrial hemp farming movement. This is a turning point for America and it’s a turning point for Hemp, Inc. Hemp, Inc. has the infrastructure in place to process millions of pounds of hemp fibers and stalks a year, on a commercial level. Our 70,000 square foot industrial hemp processing facility, on over 9 acres in Spring Hope, North Carolina, is the only one of this magnitude in North America. The industrial hemp crop is part of history in the making and it is something that will prove to be lucrative not only for the farmers in North Carolina but for Hemp, Inc. as well,” said CEO Bruce Perlowin in a recent PR.

HEMP saw a bump in volume early in October, the stock ran from $0.0276 to $0.056 before consolidating in late November/December, and has once again begun to aggressively climb back from that price channel.

hemp

Cannabis Sativa, Inc. (CBDS)
195%

With multiple subsidiaries, this company has products ranging from hemp oils & capsules to cannabidiol infused bottled water and even its own patented cannabis plan named Ecuadorian Sativa (Patent PP27,475). Back in late September the stock was trading around $2.80 per share before it jumped up to highs of $8.25. After consolidating for weeks leading up to the new year, CBDS has once again followed suit of many marijuana stocks having now climbed back above $8.

CBD

OH CANADA!

This leads us to our “neighbors up north” because we haven’t just seen a boom from US marijuana stocks alone. The trend has echoed into Canada with some of the most anticipated IPOs so far this year

Emblem Corp. (TSXVENTURE:EMC)(OTCQB:EMMBF)
55%

Emblem Corp, a Licensed Cultivator out of Paris Ontario is one of the most watched and anticipated offerings that has come out of Canada in the last few months. Beyond the fact that they are already growing cannabis and revenue producing investors have taken note of one of their founders and current President, a gentleman by the name of John Stewart.

No, not John Stewart from the Daily Show even though that would be awesome, John Stewart former CEO of Purdue Pharma one of the largest private biotech companies in the world and creators of OxyContin. We see the potential long term to create a cultivator/Biotech hybrid in which case Emblem could be the Next GW Pharma of Canada.

Marijuana IPO

InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) (CNSX: IN)
326%

This company has been following the same pattern as many of the other cannabis biotechs but also comes with what looks to be a stock promotion behind it. The company recently appointed Jeff Charpentier, CPA, CA as InMed’s Chief Financial Officer & Corporate Secretary as well as Martin Bott to its Board of Directors; Bott has worked at Eli Lilly & Company since 1988 and held a variety of roles in the U.S., Switzerland, Germany, and the UK.

InMed is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. IMLFF saw a rise in price early in October (shocker right?), a period of consolidation leading up to the new year, and since that ball dropped, the stock has been on the run moving from $0.10 in October to highs of $0.4261 just a few days ago.

Marijuana Stocks

Aurora Cannabis Inc. (TSXV: ACB) (OTCQB: ACBFF)
179%

The company’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) and operates a 55,200 square foot, expandable, state-of-the-art production facility in Mountain View County, Alberta, Canada.

They just announced that the company has officially surpassed 12,000 registered patients within the first 12 months of product sales in Canada. They also announced that they had signed a Joint Venture Research Agreement with Radient Technologies Inc. (“RTI”). The first phase of this venture will include screening experiments of extraction conditions, while phase two includes larger scale experiments related to extraction throughput and optimal extraction conditions. Aurora’s scientists and the RTI team will commence tests January 16, 2017, and the first phase is expected to be completed within approximately six weeks, so something to keep an eye on here in our opinion.

Likewise with the other stocks, the market activity has followed suit even though Aurora has differed by not breaking a new high this year as compared to the high it made in November. But the new uptrend on the chart could be a key indicator for future potential. Since October (at $1.06), shares of ACBFF has seen two and possibly three clear runs; One that saw highs of $1.89 before consolidating, another that saw highs of $2.96 before consolidating, and possibly a new uptrend forming now in January.

Buy marijuana stocks

These are just a few marijuana stocks that have demonstrated a near identical move in the market both leading into the election and leading up to the inauguration. We’ve said it before and most likely will say it again: Marijuana Stocks can very much be event driven so something to keep in the back of your head as we watch 2017 unfold. As investors become more informed on the industry itself, we’ll keep our had on the pulse to find the real story behind some of the biggest marijuana stock moves in the market today.

 

 

 

 

 


 

Pursuant to an agreement between MAPH and a non affiliate third party, we were hired for a period of 30 days to publicly disseminate information about (VBIO) including on the Website and other media including Facebook and Twitter. We are being paid $100,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VBIO) which we purchased in the open market. We plan to sell “ZERO” shares of (VBIO) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. Pursuant to an agreement between MAPH and Ubiquitech Software Corp., we were hired for a period beginning November 11 2016 and ending May 11, 2017 to publicly disseminate information about (UBQU) including on the Website and other media including Facebook and Twitter. We are being paid $0 (CASH) for or were paid “10 million” shares of restricted common shares. MAPH owns 2 million common restricted shares of mCig Inc. MAPH owns 10 million common restricted shares of Hemp Inc. An affiliate of MAPH owns 70,850 common restricted shares of Emblem Corp. We may buy or sell additional shares of any stocks mentioned, in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information

    7 3075

    We’ve all come here for one reason: Getting Information on Stocks. With most marijuana stocks being considered penny stocks, there are many things that need to be taken into account because yes, they do have higher risk than something like Microsoft or Apple…at least during the early stages of development.

    A lot of the risk comes from volatility in markets. At the drop of a hat a penny stock can explode 20, 50, 100, or even 300% within the matter of weeks or even days. The important part to pay attention to during times of increased volatility is the chart. Historic levels of support and resistance can shed some light on where there are strong points on the chart that show where a price could hold up…especially during times of a pull-back. The main point, as with any stock, is not to let emotion dictate the pace and think logically.

    During times when you get a massive short squeeze and market makers basically need to give up and cover, the second day following a major squeeze needs to be followed closely. Unless there is another monster day of bullish momentum, there’s a good chance that short traders will short even heavier to attempt to make money back after losing “yesterday”. This could trigger some very volatile days to follow and many times, periods of pull-back. The major reason for the pull-back after such a big day has more to do with where the real “retail market” is.

    Obviously a stock can’t go up every day and needs to consolidate but after such a big day on the day of a short squeeze, the market needs to find where the true retail channel is. The point is to stay calm, don’t let emotions dictate the pace. After you see such a big short squeeze, a healthy market will need to find its real base. Keep in mind that most of the time there is a short squeeze, there’s typically more buying coming from short traders and not necessarily retail buying directly. It’s normal to see a pull-back so it’s best to remain calm and pay attention to the historical levels of support and resistance.

    For example if a stock is trading around $2.50-$3.00 consistently and shows clear resistance levels around $3, there’s a good chance that a short is beginning to build in that area. Now say a short squeeze triggers, and that stock has a move above $4; that big move doesn’t necessarily mean that the market is at $4, it could just mean that there wasn’t enough resistance to hold back the price during the time that short sellers needed to buy back shares to cover their short position. Keep in mind that shorting deals with borrowing shares and not borrowing price. What we mean is that if you short a stock, you essentially are borrowing a number of shares of stock and when you need to cover your short, you need to pay back those shares.

    If you were short 100 shares at $2 and now the price is at $4 when you have to cover your short position, you would have been forced to pay double the price in order to pay back your position. This is why we say that a short squeeze doesn’t necessarily represent the true retail market. Again, there can be a lot of volatility following a short squeeze that includes panic selling and heavier shorting so it’s important to stay calm and pay close attention to the trend, sometimes cost averaging at lower prices, or even holding strong as another short squeeze could trigger. All things considered, the final decision is up to you but you should take into account these other factors especially when there is a giant spike in price and volume. A healthy market will not go up every day and taking advantage of the volatility can be where a lot of money could be made.

      0 1119

      Untitled Extract Pages1 Untitled Extract Pages2 Untitled Extract Pages3 Untitled Extract Pages4 Untitled Extract Pages5 Untitled Extract Pages6 Untitled Extract Pages7 Untitled Extract Pages8

        2 2803

        You’ve likely referred to them as “Marijuana stocks,” or “cannabis stocks” or maybe heard a friend call them “Pot Stocks.” What ever they go by, there’s no denying that the subject of Marijuana Stock investing is a topical one. Ten years ago if you told your parents you were getting into “marijuana” they would have had you pee in a cup, now it seems dad & his poker buddies or mom in the PTA are saying “How do I get into weed?”

        Today we see that the business of marijuana is not just one of cultivation and distribution. There are finance companies, consulting firms, industry analysts, security firms, real estate companies, biotechnology, tech start-ups, social media companies all involved in some ancillary vertical associated with cannabis. As the marketplace continues to grow (pun intended) we are seeing well-established industries entering the sector.

        Within the capital markets public companies keep sprouting from, it seems, out of nowhere to try and carve out their own green footprint. Cannabis stocks, as volatile as they may be, continue to captivate investors looking to grab their own piece of a brand new industry, the same way their parents did ten plus years ago with “DotCom.” Dot Bong seems to be the millennials’ turn at finding the next Ebay or Amazon. Think about it, if you could have invested in alcohol just as prohibition was ending, would you (assuming that there was an opportunity to purchase shares of a publicly traded alcohol company)? I will be presumptuous and say “yes”f or you; and that’s exactly what’s happening. Marijuana is the newest “sin” sector in the public markets, joining the likes of big tobacco, Alcohol, and Gaming industry.

        So do you know how to buy cannabis stocks VS others? It’s very simple and is the same way you would purchase shares of Coca-Cola if you wanted to. The only difference is that most of these stocks will trade on the OTC or “Over The Counter” and regulatory issues could be an obstacle for some who are looking to invest in marijuana stocks. Information is everything and being able to take on the due diligence process is of the utmost importance before considering a cannabis stock as an investment.

        A new report out from investment app SigFig shows that 1 in 8 investors have purchased so called “sin stocks”, with 7% of investors buying into tobacco companies. More than 2% of investors have been shown to support marijuana companies; while just under 2% of investors go into both casino gambling and alcohol. A new breed is rising in the market especially when considering an investment into cannabis. “Stuffy” tobacco investors are older and generally live in the South, while investors in this “new crop” of marijuana companies are more likely to live in the Northeast such as in the New York tri-state area.

        But here’s the kicker, people are always talking about “younger generations not putting money into the stock market”. But if you take a look into this study, it shows that far and away the disparity between the ages of marijuana stock investors and other “Sin stock” investors is incredibly evident.

        Sin Stocks

        The “less money” to invest is exactly what has kept many flocking to cannabis stocks to watch. Take our own Wolf of Weed Street for example, along side thousands of others who were able to take a small investment and make it work for them in BIG ways. While many of these older investors choose to lay their money up for months or even years to find a return of 10-15%, many marijuana stocks have returned 50-5,000% in the matter of days or weeks…that’s not to say that there is typically much more risk involved with small cap marijuana stocks VS the much larger tobacco and casino giants.

        When the discussion about marijuana stocks comes about, where do you stand? Do you find yourself in the same mindset of at least 7 high net worth investment funds taking the leap into buying cannabis stocks or are you still watching from the sidelines? Let us hear your thoughts below

        Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

        We are your #1 source for all things Marijuana Stocks, Subscribe Below!

        Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
        Ad Placements